Financials
- Market Capitalization 2.38 B
- Employee 370
- Founded 2016
- CEO N/A
- Website www.tarsusrx.com
- Headquarter Delaware, United States
- FIGI BBG00RB9BNQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-63.2
Relación precio/flujo de caja
5.56
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1875 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.45 USD | -2.98% | -11.27% | +3.96% | +8.00% | 2.40 B USD | ||
| 1878 | NRIX Nurix Therapeutics, Inc. - Common stock | 23.47 USD | +2.13% | -0.30% | +38.63% | +109.37% | 2.44 B USD | ||
| 1887 | VCEL Vericel Corporation - Common Stock | 47.28 USD | +2.58% | +1.63% | +23.06% | +30.07% | 2.41 B USD | ||
| 1890 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 39.75 USD | -0.43% | -7.49% | +24.30% | -8.39% | 2.36 B USD |